Drug Database
Back to search

Japan· JP-4413002F2054

プロメタジン塩酸塩

A promethazine product containing プロメタジン塩酸塩, registered in Japan by 高田製薬, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

On Japan’s NHI price listATC R06AD02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedプロメタジン塩酸塩ATCR06AD02REGISTER NO.JP-4413002F2054PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about プロメタジン塩酸塩Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Promethazine is registered in 14 of 19 countries.

Countries holding a registration under ATC R06AD02 (promethazine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 7 of them publish a price we can compare per daily dose
Search promethazine products by name

Promethazine · ATC R06AD02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
プロメタジン塩酸塩
Manufacturer
高田製薬
Country
Japan (JP)
ATC code
R06AD02
ATC class
Promethazine
Defined daily dose
25 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

976 interactions on record for promethazine.

Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check promethazine against other medicinesHow interaction checks work

Promethazine · interactions on record

976 records

  • 87 severe
  • 625 moderate
  • 19 minor
  • 245 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Promethazine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All promethazine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Bulgaria · Aнтиалeрзин
  • Cyprus · Promethazine Remedica
  • Czechia · Prothazin
  • Germany · Atosil, Atosil N
  • Denmark · Phenergan, Prometazin Actavis
  • Spain · Fenergan
  • France · Phenergan
  • United Kingdom (Northern Ireland) · Phenergan, Phenergan Elixir
  • Greece · Fenimezyl, Prugal-Derm
  • Hungary · Pipolphen
  • Ireland · Phenergan
  • Iceland · Phenergan, Prometazin Actavis
  • Italy · Alontan Antistaminico, Fadezin
  • Malta · Fenazil, Promethazine Remedica
  • Netherlands · Promethazine Ace, Promethazine Cf
  • Norway · Phenergan
  • Poland · Diphergan, Polfergan
  • Portugal · Prometazina Basi, Prometazina Medlink
  • Sweden · Farghess, Lergigan
  • Slovakia · Prothazin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f92be8e4-2b70-4f17-9bad-42ac0e202f95
GET /v1/drugs/f92be8e4-2b70-4f17-9bad-42ac0e202f95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "２５ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "4413002F2054",
  "category": "内用薬",
  "price_yen": 6.3,
  "generic_name": "プロメタジン塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "4413",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about promethazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console